Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

KNSA holding history

Kiniksa Pharmaceuticals International, plc in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KNSA overviewAll 13F holders of KNSAFull Q4 2025 holdings

Shares (Q4 2025)
3,112,937
Value
$128.4M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of KNSA by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20253,112,937$128.4M<0.1%+49,802+1.6%AddedHolders
Q3 20253,063,135$118.9M<0.1%−68,467−2.2%ReducedHolders
Q2 20253,131,602$86.7M<0.1%−227,499−6.8%ReducedHolders
Q1 20253,359,101$74.6M<0.1%+151,604+4.7%AddedHolders
Q4 20243,207,497$63.4M<0.1%−90,759−2.8%ReducedHolders
Q3 20243,298,256$82.4M<0.1%+3,298,256NewHolders
Q2 20240$00.0%−2,981,894−100.0%Sold outHolders
Q1 20242,981,894$58.8M<0.1%+16,595+0.6%AddedHolders
Q4 20232,965,299$52.0M<0.1%+6,342+0.2%AddedHolders
Q3 20232,958,957$51.4M<0.1%−128,255−4.2%ReducedHolders
Q2 20233,087,212$43.5M<0.1%−173,411−5.3%ReducedHolders
Q1 20233,260,623$35.1M<0.1%+33,732+1.0%AddedHolders
Q4 20223,226,891$48.3M<0.1%+147,699+4.8%AddedHolders
Q3 20223,079,192$39.5M<0.1%+151,211+5.2%AddedHolders
Q2 20222,927,981$28.4M<0.1%−78,669−2.6%ReducedHolders
Q1 20223,006,650$29.9M<0.1%+115,942+4.0%AddedHolders
Q4 20212,890,708$34.0M<0.1%+228,082+8.6%AddedHolders
Q3 20212,662,626$30.3M<0.1%−1,697−0.1%ReducedHolders
Q2 20212,664,323$37.1M<0.1%−138,724−4.9%ReducedHolders
Q1 20212,803,047$51.9M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.